ObsEva SA announced the resignation of Jean-Pierre Gotteland, Chief Scientific Officer and Head of Research & Development, effective September 30, 2022. Dr. Gotteland will step down from the Company's Executive Committee, effective immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% |
|
0.00% | -100.00% |
2023 | ObsEva to Suspend Reporting With SEC Following Delisting From Nasdaq | MT |
2023 | ObsEva to Change Central Securities Depositary to SIX SIS; Shares Up 9% | MT |
1st Jan change | Capi. | |
---|---|---|
-100.00% | 117 | |
+15.58% | 121B | |
+16.60% | 110B | |
+18.81% | 25.93B | |
-24.33% | 19.27B | |
-19.33% | 16.01B | |
-17.95% | 15.66B | |
-46.81% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- OBSEF Stock
- News ObsEva SA
- ObsEva SA Announces Management Change